Cargando…

Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl(4)-Induced Skeletal Muscle Injury

TGF-β1 is known to inhibit muscle regeneration after muscle injury. However, it is unknown if high systemic levels of TGF-β can affect the muscle regeneration process. In the present study, we demonstrated the effect of a CCl(4) intra-peritoneal injection and losartan (an angiotensin II type 1 recep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Ok-Kyung, Park, Jin-Kyu, Lee, Eun-Joo, Lee, Eun-Mi, Kim, Ah-Young, Jeong, Kyu-Shik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783959/ https://www.ncbi.nlm.nih.gov/pubmed/26867195 http://dx.doi.org/10.3390/ijms17020227

Ejemplares similares

Effect of Angiotensin II Type 1 Receptor Antagonist, Losartan on Inflammatory Factor in Atherosclerotic Rabbits
por: Xu, Yan-min, et al.
Publicado: (2013)

Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells
por: Panza, Salvatore, et al.
Publicado: (2021)

Pathomorphological features of calcinosis circumscripta in a dog
por: Lee, Eun-Mi, et al.
Publicado: (2016)

Increased Susceptibility of Radiation-Induced Intestinal Apoptosis in SMP30 KO Mice
por: Goo, Moon-Jung, et al.
Publicado: (2013)

Canine hemangiosarcoma in a female Jindo dog
por: Mun, Ahlyum, et al.
Publicado: (2011)

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra
por: Grammatopoulos, Tom N, et al.
Publicado: (2007)

Nox2 signaling and muscle fiber remodeling are attenuated by losartan administration during skeletal muscle unloading
por: Hord, Jeffrey M., et al.
Publicado: (2021)

Splenic angiomyxoma with intravascular tumor embolus in a dog: a case report
por: LEE, Eun-Mi, et al.
Publicado: (2016)

Histopathological Features of Myxoid Pleomorphic Liposarcoma in an African Pygmy Hedgehog (Atelerix Albiventris)
por: Lee, Eun-Joo, et al.
Publicado: (2022)

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
por: Miao, Y., et al.
Publicado: (2010)

Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice
por: Bish, Lawrence T., et al.
Publicado: (2011)

The Angiotensin Type 1 Receptor Antagonist Losartan Prevents Ovariectomy-Induced Cognitive Dysfunction and Anxiety-Like Behavior in Long Evans Rats
por: Campos, Glenda V., et al.
Publicado: (2019)

Smad3 Deficiency Ameliorates Hepatic Fibrogenesis through the Expression of Senescence Marker Protein-30, an Antioxidant-Related Protein
por: Jeong, Da-Hee, et al.
Publicado: (2013)

Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
por: Miao, Y., et al.
Publicado: (2011)

Ligand-activated PPARδ inhibits angiotensin II-stimulated hypertrophy of vascular smooth muscle cells by targeting ROS
por: Kang, Eun Sil, et al.
Publicado: (2019)

Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells
por: GUO, YAN-SONG, et al.
Publicado: (2015)

Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24
por: Cho, Hyuck, et al.
Publicado: (2016)

Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis
por: Wang, Di, et al.
Publicado: (2013)

Losartan protects human stem cell-derived cardiomyocytes from angiotensin II-induced alcoholic cardiotoxicity
por: Song, Yuanxiu, et al.
Publicado: (2022)

Unveiling Angiotensin II and Losartan-Induced Gene Regulatory Networks Using Human Urine-Derived Podocytes
por: Thimm, Chantelle, et al.
Publicado: (2023)

Angiotropic metastatic malignant melanoma in a canine mammary gland
por: Yang, Hai Jie, et al.
Publicado: (2011)

Angiotensin II Infusion Induces Marked Diaphragmatic Skeletal Muscle Atrophy
por: Rezk, Bashir M., et al.
Publicado: (2012)

Alcohol Induced Hepatic Degeneration in a Hepatitis C Virus Core Protein Transgenic Mouse Model
por: Noh, Dong-Hyung, et al.
Publicado: (2014)

Reference Values for Skeletal Muscle Mass at the Third Lumbar Vertebral Level Measured by Computed Tomography in a Healthy Korean Population
por: Yoon, Ja Kyung, et al.
Publicado: (2021)

Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer
por: Hashemzehi, Milad, et al.
Publicado: (2021)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats
por: Chang, Sung-A, et al.
Publicado: (2015)

TRPCs: Influential Mediators in Skeletal Muscle
por: Choi, Jun Hee, et al.
Publicado: (2020)

Angiotensin II Reduces Mitochondrial Content in Skeletal Muscle and Affects Glycemic Control
por: Mitsuishi, Masanori, et al.
Publicado: (2009)

Human and Rodent Skeletal Muscles Express Angiotensin II Type 1 Receptors
por: Deminice, Rafael, et al.
Publicado: (2020)

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat
por: Yoshiji, Hitoshi, et al.
Publicado: (2009)

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects
por: Takagi, Hirotetsu, et al.
Publicado: (2021)

Secondary renal tubular dysgenesis in a newborn exposed to angiotensin Ⅱ receptor antagonist during gestation
por: Gang, Mi Hyeon, et al.
Publicado: (2020)

Resistive index as a predictor of renal progression in patients with moderate renal dysfunction regardless of angiotensin converting enzyme inhibitor or angiotensin receptor antagonist medication
por: Kim, Jae Hoon, et al.
Publicado: (2017)

Clusterin/Apolipoprotein J Attenuates Angiotensin II-Induced Renal Fibrosis
por: Jung, Gwon-Soo, et al.
Publicado: (2014)

Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study
por: Choi, YoonJung, et al.
Publicado: (2016)

Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin II
por: Macconi, Daniela, et al.
Publicado: (2015)

Angiotensin II Inhibits Insulin Binding to Endothelial Cells
por: Oh, Su-Jin, et al.
Publicado: (2011)

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
por: Coulson, Rhiannon, et al.
Publicado: (2017)

Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands
por: Cano, Isadora Prado, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nrl655fthoits0ilp00nelnmnd